vimarsana.com

Page 10 - டாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Serum Institute Seeks DGCI s Nod to Manufacture Russian Vaccine Sputnik V in India

Serum Institute Seeks DCGI s Nod to Manufacture Russian Vaccine Sputnik V in India News18 56 minutes ago News18 © Provided by News18 Serum Institute Seeks DCGI s Nod to Manufacture Russian Vaccine Sputnik V in India After Oxford-AstraZeneca’s Covishield vaccine and Novovax’s Covovax, the Serum Institute of India on Wednesday has applied to get a nod from the Drug Controller General of India (DCGI) to make the Sputnik V Covid-19 vaccine in India. Russia’s Sputnik V vaccine is currently being manufactured by Dr Reddy’s Laboratories. The SII has sought the DCGI’s permission for test analysis and examination. In case, it receives a go-ahead, an emergency use authorisation (EUA) would be required, the

Andhra pradeshRussian federationOxford astrazeneca covishieldNovovax covovaxSerum institute of india onNational research centerGamaleya instituteSerum institute seeksSerum instituteDr reddy laboratories ltdInstitute seeksDrug controller generalFinancial expressHyderabad airportAir cargoLaboratories ltd

U S Multiple Myeloma Diagnostic Market Research Report, Growth Trends and Competitive Analysis 2021-2027 – KSU

The global U.S Multiple Myeloma Diagnostic Market size is projected to grow from USD XX million in 2020 to USD XX million by 2027, at a CAGR of XX %.

Janssen pharmaceuticals incSun pharmaceutical industries ltdDr reddy laboratories ltdGw pharmaceuticalsTeva pharmaceutical industries ltdPfizer incAbbvie incJohnson services incApotex incAmneal pharmaceuticalsAlembic pharmaceuticalsEndo internationalViatris incHikma pharmaceuticalsVistapharm incJanssen pharmaceuticals

U S Tuberous Sclerosis Drugs Market Research Report, Growth Trends and Competitive Analysis 2021-2027 – KSU

The global U.S. Tuberous Sclerosis Drugs Market size is projected to grow from USD XX million in 2020 to USD XX million by 2027, at a CAGR of XX %. T

Janssen pharmaceuticals incSun pharmaceutical industries ltdDr reddy laboratories ltdGw pharmaceuticalsTeva pharmaceutical industries ltdPfizer incAbbvie incJohnson services incApotex incAmneal pharmaceuticalsAlembic pharmaceuticalsEndo internationalViatris incHikma pharmaceuticalsVistapharm incSclerosis drugs market

Govt expects speedy India launch of single-dose Sputnik Light to boost COVID-19 vaccination drive

Drugs Controller General of India (DCGI) informed other participants that the application for regulatory approval of Sputnik Light is expected to be filed in the next 2-3 weeks.

Russian federationAnju narayananUnion health ministryNational research centerHealth ministryCentral drugs standard control organisationDr reddy laboratories ltdDepartment of biotechnologyRussian direct investment fundGamaleya instituteSerum instituteMinistry of external affairsSputnik lightCabinet secretaryBiotechnology secretaryDrugs controller general

If approved, Sputnik Light could become first single-dose vaccine to be launched in India

The two-dose Sputnik V had received the Indian drug regulator's permission for restricted emergency use with certain conditions on April 12. Dr Reddy's Laboratories is importing the vaccine for use in India.

New delhiRussian federationUnion health ministryNational research centerHealth ministryCentral drugs standard control organisationDr reddy laboratories ltdDepartment of biotechnologyRussian direct investment fundGamaleya instituteSerum instituteMinistry of external affairsSputnik lightCabinet secretaryBiotechnology secretaryDrugs controller general

vimarsana © 2020. All Rights Reserved.